Shin-Ichi Tsujimoto

Shin-Ichi Tsujimoto

Auto-generated profile, based on publicly available information

Shin-Ichi Tsujimoto

Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2024 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
WNWataru Nakamura
Wataru Nakamura
MHMakoto Hirata
Makoto Hirata
SOSatoyo Oda
Satoyo Oda
KCKenichi Chiba
Kenichi Chiba
AOAi Okada
Ai Okada
YSYuichi Shiraishi
Yuichi Shiraishi
Innovations in sequencing technology have led to the discovery of novel mutations that cause inherited diseases. However, many patients with suspected genetic diseases remain undiagnosed. Long-read sequencing technologies are expected to significantly improve the diagnostic rate by overcoming the limitations of short-read sequencing. In addition, Oxford Nanopore Technologies (ONT) offers adaptive sampling and computationally driven target enrichment technology. This enables more affordable intensive analysis of target gene regions compared to standard non-selective long-read sequencing. In this study, we developed an efficient computational workflow for target adaptive sampling long-read sequencing (TAS-LRS) and evaluated it through application to 33 genomes collected from suspected hereditary cancer patients. Our workflow can identify single nucleotide variants with nearly the same accuracy as the short-read platform and elucidate complex forms of structural variations. We also newly identified several SINE-R/VNTR/Alu (SVA) elements affecting the APC gene in two patients with familial adenomatous polyposis, as well as their sites of origin. In addition, we demonstrated that off-target reads from adaptive sampling, which is typically discarded, can be effectively used to accurately genotype common single-nucleotide polymorphisms (SNPs) across the entire genome, enabling the calculation of a polygenic risk score. Furthermore, we identified allele-specific MLH1 promoter hypermethylation in a Lynch syndrome patient. In summary, our workflow with TAS-LRS can simultaneously capture monogenic risk variants including complex structural variations, polygenic background as well as epigenetic alterations, and will be an efficient platform for genetic disease research and diagnosis.

18 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DTDaisuke Tomizawa
Daisuke Tomizawa
STShin-Ichi Tsujimoto
Shin-Ichi Tsujimoto
Acute Myeloid Leukemia (AML) is the second most common type of leukemia in children. Recent advances in high-resolution genomic profiling techniques have uncovered the mutational landscape of pediatric AML as distinct from adult AML. Overall survival rates of children with AML have dramatically improved in the past 40 years, currently reaching 70% to 80% in developed countries. This was accomplished by the intensification of conventional chemotherapy, improvement in risk stratification using leukemia-specific cytogenetics/molecular genetics and measurable residual disease, appropriate use of allogeneic hematopoietic stem cell transplantation, and improvement in supportive care. However, the principle therapeutic approach for pediatric AML has not changed substantially for decades and improvement in event-free survival is rather modest. Further refinements in risk stratification and the introduction of emerging novel therapies to contemporary therapy, through international collaboration, would be key solutions for further improvements in outcomes.

22 January 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
TOTomoo Osumi
Tomoo Osumi
STShin‐Ichi Tsujimoto
Shin‐Ichi Tsujimoto
KNKazuhiko Nakabayashi
Kazuhiko Nakabayashi
MTMaki Taniguchi
Maki Taniguchi
RSRyota Shirai
Ryota Shirai
MKMotohiro Kato
Motohiro Kato

6 November 2023 in Leukemia
Verified
Journal Article
Closed access
PDF file
DTDaisuke Tomizawa
Daisuke Tomizawa
JMJun Matsubayashi
Jun Matsubayashi
SIShotaro Iwamoto
Shotaro Iwamoto
HHHidefumi Hiramatsu
Hidefumi Hiramatsu
DHDaisuke Hasegawa
Daisuke Hasegawa
SASouichi Adachi
Souichi Adachi

13 December 2021 in Blood Advances
Verified
Journal Article
Open access
PDF file
MYMasanori Yoshida
Masanori Yoshida
KNKazuhiko Nakabayashi
Kazuhiko Nakabayashi
WYWentao Yang
Wentao Yang
ASAiko Sato-Otsubo
Aiko Sato-Otsubo
STShin-Ichi Tsujimoto
Shin-Ichi Tsujimoto
MKMotohiro Kato
Motohiro Kato
The effect of genetic variation on second malignant neoplasms (SMNs) remains unclear. First, we identified the pathogenic germline variants in cancer-predisposing genes among 15 children with SMNs after childhood leukemia/lymphoma using whole-exome sequencing. Because the prevalence was low, we focused on the association between SMNs and NUDT15 in primary acute lymphoblastic leukemia (ALL) cases. NUDT15 is one of the 6-mercaptopurine (6-MP) metabolic genes, and its variants are common in East Asian individuals. The prevalence of NUDT15 hypomorphic variants was higher in patients with SMNs (n = 14; 42.9%) than in the general population in the gnomAD database (19.7%; P = .042). In the validation study with a cohort of 438 unselected patients with ALL, the cumulative incidence of SMNs was significantly higher among those with (3.0%; 95% confidence interval [CI], 0.6% to 9.4%) than among those without NUDT15 variants (0.3%; 95% CI, 0.0% to 1.5%; P = .045). The 6-MP dose administered to patients with ALL with a NUDT15 variant was higher than that given to those without SMNs (P = .045). The 6-MP–related mutational signature was observed in SMN specimens after 6-MP exposure. In cells exposed to 6-MP, a higher level of 6-MP induced DNA damage in NUDT15-knockdown induced pluripotent stem cells. Our study indicates that NUDT15 variants may confer a risk of SMNs after treatment with 6-MP in patients with ALL.

18 April 2024 in Leukemia
Verified
Journal Article
Closed access
PDF file
SIShinju Iyoda
Shinju Iyoda
KYKenichi Yoshida
Kenichi Yoshida
KSKota Shoji
Kota Shoji
NINana Ito
Nana Ito
MTMiu Tanaka
Miu Tanaka
HMHidemasa Matsuo
Hidemasa Matsuo